What is Streamline?
Streamline, Inc. operates at the intersection of medical device management and hospital operational efficiency. The company provides a proprietary technology platform designed to address the persistent challenge of managing bulky IV poles and mounted infusion pumps during patient care and intra-hospital transport. By enabling the seamless mounting of the Integrated Support System (ISS) to any standard hospital bed or stretcher, Streamline effectively mitigates the risks associated with equipment instability and caregiver strain. This solution is critical for modern healthcare facilities aiming to optimize clinical workflows and enhance patient safety during transit, positioning the firm as a vital partner in the evolution of hospital logistics.
How much funding has Streamline raised?
Streamline has raised a total of $250K across 1 funding round:
Debt
$250K
Debt (2025): $250K with participation from BankVista
Key Investors in Streamline
BankVista
A financial institution providing specialized debt financing and capital solutions to support the growth and operational scaling of emerging healthcare technology firms.
What's next for Streamline?
Following this late-stage capital injection, Streamline is expected to prioritize the widespread deployment of its ISS technology across major healthcare networks. The strategic focus will likely shift toward deepening market penetration and refining the integration of its hardware with existing hospital infrastructure. By utilizing this debt financing to bolster its supply chain and manufacturing capacity, the company aims to address the growing demand for ergonomic and safe patient transport solutions. As the healthcare industry continues to emphasize operational excellence and risk reduction, Streamline is poised to transition from a niche innovator to a standard-bearer in medical equipment management, potentially exploring further R&D to expand its product ecosystem.
See full Streamline company page
